Showing results (201-210 of 237) with videos related to
Sort By:
Pageof 24
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.JAMA Cardiology|March 31, 2025
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical TrialAdam N Berman, Michael K Hidrue, Curtis Ginder, et al.Journal of Neurosurgery|May 6, 2022
The New England Neurosurgical Society: growth and evolution over 70 yearsAndy Y Wang, Vaishnavi Sharma, Wenya Linda Bi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed GlioblastomaManmeet S Ahluwalia, David A Reardon, Ajay P Abad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.Pageof 24